ACR Convergence 2025| Tips for Starting Your Own Rheumatology Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: liver

Opening a New Therapeutic Window for Rheumatoid Arthritis

Ann Kepler  |  January 13, 2012

New targets in rheumatoid arthritis: SYK, JAK, BTK

Filed under:Biologics/DMARDsConditionsDrug UpdatesMeeting ReportsResearch RheumRheumatoid Arthritis Tagged with:ACR/ARHP Annual Meetinganti-inflammatoryBiologicsdrugImmunologyJAK inhibitorsjanus kinasepatient careResearchRheumatoid arthritis

Quality Measurement Improves Rheumatology Outcomes

Kathleen Louden  |  January 13, 2012

Innovations in health information technology can have significant impact

Filed under:ConditionsDrug UpdatesInformation TechnologyMeeting ReportsOsteoarthritis and Bone DisordersPractice SupportQuality Assurance/ImprovementResearch RheumTechnology Tagged with:AC&RACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)drugGlucocorticoidsOsteoporosispatient carePractice ManagementQualityRAResearchRheumatoid arthritisrheumatologistSafetyTechnology

Drug Updates: Apremilast, Belimumab, and More

Michele B. Kaufman, PharmD, BCGP  |  January 13, 2012

Information on new approvals and medication safety

Filed under:Axial SpondyloarthritisBiologics/DMARDsConditionsDrug UpdatesPsoriatic ArthritisSystemic Lupus Erythematosus Tagged with:Ankylosing Spondylitisanti-inflammatoryApprovalsBiologicsdrugJAK inhibitorsjanus kinaseMethotrexatePipelinePsoriatic ArthritisSafetySystemic lupus erythematosus

A Productive Year Ahead

James R. O'Dell, MD  |  December 12, 2011

Rheumatologists face challenges and unique opportunities in the coming year

Filed under:Education & TrainingPresident's PerspectiveProfiles Tagged with:AC&RAdvocacyVolunteer

Data Rich, Information Poor

Staff  |  December 12, 2011

Did you know that the health information stored by your practice could be one of your most valuable assets?

Filed under:Billing/CodingEMRsTechnology Tagged with:electronic health recordPractice ManagementTechnology

Planning the ACR/ARHP Annual Scientific Meeting

Joel A. Block, MD  |  December 12, 2011

As the 2011 ACR/ARHP Annual Scientific Meeting ends, those of us on the Annual Meeting Planning Committee (AMPC) take time to reflect on the process and on the product.

Filed under:Education & TrainingFrom the College Tagged with:2011 ACR/ARHP Annual Scientific MeetingACR/ARHPEducationrheumatologyTraining

Old Drugs Can Learn New Tricks

Staff  |  November 1, 2011

Methotrexate and its mechanism of action

Filed under:ConditionsDrug UpdatesRheumatoid Arthritis Tagged with:AdenosineDrugsMethotrexateRARheumatoid arthritis

The Microbiome

Jose U. Scher, MD, Steven B. Abramson, MD  |  November 1, 2011

A voyage to (our inner) Lilliput

Filed under:ConditionsResearch RheumRheumatoid Arthritis Tagged with:bacteriaMicrobiomePathogenesisRAResearchRheumatoid arthritis

A Look Back with Pride and Appreciation

David Borenstein, MD  |  November 1, 2011

The many accomplishments of the past year set the stage for a bright, busy future

Filed under:Legislation & AdvocacyPresident's Perspective Tagged with:AC&RAdvocacyAdvocates for ArthritisLupus InitiativePainrheumatology

Rheumatology Professionals and Patient Advocates Take Their Stories to Capitol Hill

Staff  |  November 1, 2011

The ACR’s annual Advocates for Arthritis conference, September 19–20, brought more than 120 rheumatologists, rheumatology health professionals, and patient advocates to our nation’s capital. Attendees, representing 37 states, met with more than 175 congressional offices, sharing their stories of access to care, treatment, and the importance of research.

Filed under:From the CollegeLegislation & Advocacy Tagged with:AdvocacyAdvocates for ArthritisCongressLegislationpatient carerheumatology

  • « Previous Page
  • 1
  • …
  • 108
  • 109
  • 110
  • 111
  • 112
  • …
  • 127
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences